Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quanterix Corporation - Common Stock (NQ:QTRX)

4.890 -0.260 (-5.05%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 519,032
Open 5.060
Bid (Size) 4.890 (167)
Ask (Size) 4.940 (22)
Prev. Close 5.150
Today's Range 4.815 - 5.060
52wk Range 4.670 - 19.18
Shares Outstanding 38,063,618
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AKYA, CKPT, QTRX on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders
From Kent Lake PR LLC
Via Business Wire

Performance

YTD
-54.6%
-54.6%
1 Month
-32.0%
-32.0%
3 Month
-49.7%
-49.7%
6 Month
-60.4%
-60.4%
1 Year
-70.0%
-70.0%

More News

Read More
Kent Lake Comments on Quanterix’s Value Destructive Bridge Financing for Financially Troubled Akoya
From Kent Lake PR LLC
Via Business Wire
Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit
From Quanterix Corporation
Via Business Wire
Goldman Sachs To Rally Around 8%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Quanterix Releases Financial Results for the Fourth Quarter of 2024
From Quanterix Corporation
Via Business Wire
Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today’s Earnings Call
From Kent Lake PR LLC
Via Business Wire
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
From Akoya Biosciences, Inc.
Via GlobeNewswire
Earnings Scheduled For March 17, 2025
Via Benzinga
Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025
From Quanterix Corporation
Via Business Wire
Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix’s Proposed Merger with Akoya Biosciences
From Kent Lake PR LLC
Via Business Wire
Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board
From Kent Lake PR LLC
Via Business Wire
Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition
From Quanterix Corporation
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Quanterix, e.l.f. Beauty, and Silvaco and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company’s Proposed Merger with Akoya Biosciences
From Kent Lake PR LLC
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IVAC, AVTE, QTRX on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Quanterix Investor News: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Quanterix and TransMedics and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LGTY, AZPN, RDW, QTRX on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CCRN, NARI, VTS, QTRX on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NARI, QTRX, CTV on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire

Frequently Asked Questions

Is Quanterix Corporation - Common Stock publicly traded?
Yes, Quanterix Corporation - Common Stock is publicly traded.
What exchange does Quanterix Corporation - Common Stock trade on?
Quanterix Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Quanterix Corporation - Common Stock?
The ticker symbol for Quanterix Corporation - Common Stock is QTRX on the Nasdaq Stock Market
What is the current price of Quanterix Corporation - Common Stock?
The current price of Quanterix Corporation - Common Stock is 4.890
When was Quanterix Corporation - Common Stock last traded?
The last trade of Quanterix Corporation - Common Stock was at 04/21/25 04:00 PM ET
What is the market capitalization of Quanterix Corporation - Common Stock?
The market capitalization of Quanterix Corporation - Common Stock is 186.13M
How many shares of Quanterix Corporation - Common Stock are outstanding?
Quanterix Corporation - Common Stock has 186M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.